SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?
15 references·3 citing·40 second hop
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making? (2018)Open innovation and external sources of i…Changing R&D models in research-based pharmaceutical companies (2016)Changing R&D models in resear…What Have We Learned from 40 Years of Supporting Research and Capacity Building? (2015)What Have We Learned from 40 …Crowdsourcing-Based Business Models: How to Create and Capture Value (2015)Crowdsourcing-Based Business …Models for open innovation in the pharmaceutical industry (2013)Models for open innovation in…Public-private partnerships need honest brokering (2012)Public-private partnerships n…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Grants4Targets – an innovative approach to translate ideas from basic research into novel drugs (2010)Grants4Targets – an innovativ…Lessons from 60 years of pharmaceutical innovation (2009)Lessons from 60 years of phar…The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level (2008)The Innovative Medicines Init…The FDA Critical Path Initiative and Its Influence on New Drug Development (2008)The FDA Critical Path Initiat…Drug discovery: new models for industry–academic partnerships (2008)Drug discovery: new models fo…Open Innovation: The New Imperative For Creating and Profiting From Technology (2004)Open Innovation: The New Impe…Trends and determinants of managing virtual R&D teams (2003)Trends and determinants of ma…The Human Genome Project: Lessons from Large-Scale Biology (2003)The Human Genome Project: Les…Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)Open Innovation: The New Impe…Open innovation: A paradigm shift in pharma R&D? (2022)Open innovation: A paradigm s…A New Digital Value Chain Model with PLC in Biopharmaceutical Industry: The Implication for Open Innovation (2022)A New Digital Value Chain Mod…The present and future of project management in pharmaceutical R&D (2020)The present and future of pro…Can the pharmaceutical industry reduce attrition rates? (2004)The antecedents of open business models: an exploratory study of incumbent firms (2014)The Timing of Codevelopment Alliances in New Product Development Processes: Returns for Upstream and Downstream Partners (2014)The role of management support for the implementation of open innovation practices in firms (2020)Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)The price of innovation: new estimates of drug development costs (2003)The black swan: the impact of the highly improbable (2007)The productivity crisis in pharmaceutical R&D (2011)THE WORLD MEDICINES SITUATION 2011 (2011)Drug discovery in pharmaceutical industry: productivity challenges and trends (2012)Case Study Research: Design and Methods (1984)The Knowledge-Creating Company (1995)Spaces for Creativity and Innovation in Two Established Organizations (2005)Case study research: design and methods (2011)Virtual Teams: Opportunities and Challenges for e-Leaders (2014)Managing collaborative research projects: A synthesis of project management literature and directives for future research (2015)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Tracking biocultural pathways in population health: The value of biomarkers (2009)FDA's Expedited Approval Mechanisms for New Drug Products (2015)Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality (2016)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Health metrics and evaluation: strengthening the science (2008)The Economics of Science (2010)Handbook of Self-Regulation of Learning and Performance (2017)Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance (2007)Business Model Innovation: Opportunities and Barriers (2009)The Business Model: Recent Developments and Future Research (2011)Developing a framework for responsible innovation (2013)Digital Innovation Management: Reinventing Innovation Management Research in a Digital World (2017)The digital transformation of innovation and entrepreneurship: Progress, challenges and key themes (2019)Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry (2018)Multinational enterprises and intangible capital (2021)Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design (2021)The impact of sellers' social influence on the co-creation of innovation with customers and brand awareness in online communities (2015)Business model innovation and value-creation: the triadic way (2018)Open innovation in SMEs: A process view towards business model innovation (2021)
this work references cited by second hop

References

  • 2003Open Innovation: The New Imperative for Creating and Profiting from Technology9,367 cited
  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
  • 2004Open Innovation: The New Imperative For Creating and Profiting From Technology2,652 cited
  • 2003The Human Genome Project: Lessons from Large-Scale Biology1,284 cited
  • 2009Lessons from 60 years of pharmaceutical innovation1,207 cited
  • 2008The FDA Critical Path Initiative and Its Influence on New Drug Development435 cited
  • 2016Changing R&D models in research-based pharmaceutical companies286 cited
  • 2003Trends and determinants of managing virtual R&D teams253 cited
  • 2015Crowdsourcing-Based Business Models: How to Create and Capture Value183 cited
  • 2013Models for open innovation in the pharmaceutical industry148 cited
  • 2008Drug discovery: new models for industry–academic partnerships140 cited
  • 2015What Have We Learned from 40 Years of Supporting Research and Capacity Building?33 cited
  • 2010Grants4Targets – an innovative approach to translate ideas from basic research into novel drugs32 cited
  • 2008The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level29 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2012Public-private partnerships need honest brokering19 cited
  • Cited by

    • 2022Open innovation: A paradigm shift in pharma R&D?51 cited
    • 2022A New Digital Value Chain Model with PLC in Biopharmaceutical Industry: The Implication for Open Innovation17 cited
    • 2020The present and future of project management in pharmaceutical R&D10 cited